Skip to Content
  • Previous Rank
    130
  • Revenues ($M)
    $22,991
  • Revenue Percent Change
    6.1%
  • Profits ($M)
    $7,722
  • Profits Percent Change
    11.3%
  • Assets ($M)
    $77,626
  • Employees
    19,200
  • Market Value — as of March 31, 2017 ($M)
    $120,830

The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in nearly 100 countries.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
Robert A. Bradway
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Thousand Oaks, CA
Websitehttp://www.amgen.com
Years on Fortune 500 List18
Employees19,200

Amgen Rank History

placeholder

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,9916.1%
Profits ($M)$7,72211.3%
Assets ($M)$77,626-
Total Stockholder Equity ($M)$29,875-
Market Value — as of March 31, 2017 ($M)$120,830-

Profit Ratios

Profit as % of Revenues33.6%
Profits as % of Assets9.9%
Profits as % of Stockholder Equity25.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)10.24
EPS % Change (from 2015)13%
EPS % Change (5 year annual rate)20.4%
EPS % Change (10 year annual rate)15.2%

Total Return

Total Return to Investors (2016)-7.5%
Total Return to Investors (5 year, annualized)20.3%
Total Return to Investors (10 year, annualized)9.1%